BRANDY MORRISON: Open Payments
NPI 1285335711 · AUSTIN, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,269 in 56 payments from 13 companies in 2025. Trend: 2023 $864 · 2024 $1,324 · 2025 $1,269
Food & beverage: $1,269
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 14 | $306 |
| Janssen Biotech, Inc. | 8 | $231 |
| PFIZER INC. | 10 | $230 |
| Sumitomo Pharma America, Inc. | 11 | $202 |
| Teleflex LLC | 3 | $44 |
| BIOTISSUE HOLDINGS INC. | 1 | $41 |
| Bayer Healthcare Pharmaceuticals Inc. | 2 | $40 |
| Olympus America Inc. | 1 | $39 |
| Ferring Pharmaceuticals Inc. | 2 | $38 |
| Procept Biorobotics Corporation | 1 | $34 |
Products named: BOTOX, ERLEADA, XTANDI, ORGOVYX, GEMTESA, Nubeqa, iTIND System, ADSTILADRIN.
Industry payments across TX — which companies pay providers there.
